Annual Review
Kamux Corporation's Annual Report 2023 has been published
HÄMEENLINNA, Finland, March 25, 2024 /PRNewswire/ -- Kamux Corporation's Annual Report 2023 has been published. The Annual Report consists of the Annual Review, the Board of Director's Report, the Financial Statements and the Auditor's Report, as well as the Corporate Governance Statement and the Remuneration Report 2023.
- HÄMEENLINNA, Finland, March 25, 2024 /PRNewswire/ -- Kamux Corporation's Annual Report 2023 has been published.
- The Annual Report consists of the Annual Review, the Board of Director's Report, the Financial Statements and the Auditor's Report, as well as the Corporate Governance Statement and the Remuneration Report 2023.
- Kamux publishes the Finnish language version of the Annual Report in accordance with the European Single Electronic Format (ESEF) reporting requirements as an XHTML file.
- The Annual Report is attached to this release as a PDF file.
Caverion Corporation's Annual Review 2023 is published
HELSINKI, Feb. 29, 2024 /PRNewswire/ -- Caverion Corporation's Annual Review 2023 has been published today. The Annual Review includes the Board of Directors' Report including Disclosure regarding non-financial information, the consolidated financial statements (IFRS), the parent company financial statements (FAS) and the Auditors' report.
- HELSINKI, Feb. 29, 2024 /PRNewswire/ -- Caverion Corporation's Annual Review 2023 has been published today.
- The Annual Review includes the Board of Directors' Report including Disclosure regarding non-financial information, the consolidated financial statements (IFRS), the parent company financial statements (FAS) and the Auditors' report.
- In addition, Caverion has published its Corporate Governance Statement, Remuneration Report and Sustainability Report for 2023.
- The Annual Review, the Corporate Governance Statement, the Remuneration Report and the Sustainability Report are attached to this release as PDF files and the Annual Review containing the official Financial Statements also as an XHTML file.
Valmet has published the Annual Report, the Corporate Governance Statement and the Remuneration Report for 2023
The Annual Report consists of three separate parts: the Annual Review, the Financial Statements and Report of the Board of Directors and the GRI Supplement.
- The Annual Report consists of three separate parts: the Annual Review, the Financial Statements and Report of the Board of Directors and the GRI Supplement.
- The Financial Statements and Report of the Board of Directors report includes Valmet's Financial Statements and the Report of the Board of Directors for 2023.
- Valmet has also published its Corporate Governance Statement and Remuneration Report for 2023.
- The Annual Review, the Financial Statements and Report of the Board of Directors, the GRI Supplement, the Corporate Governance Statement and the Remuneration Report are attached to this stock exchange release.
Correction to Stock Exchange Release: Finnvera's Annual Review and Sustainability Report 2023
Correction to Stock Exchange Release: Finnvera's Annual Review and Sustainability Report 2023
- Correction to Stock Exchange Release: Finnvera's Annual Review and Sustainability Report 2023
The issuer is solely responsible for the content of this announcement. - Correction to Stock Exchange Release: Finnvera's Annual Review and Sustainability Report 2023
On 15 February 2024, as part of the annual report, Finnvera published the Annual Review and Sustainability Report 2023, which included incorrect figures in the table describing Finnvera's carbon footprint. - The corrected figures are below and on page 24 of the attached Annual Review and Sustainability Report 2023.
Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence
Effectively implemented on January 16, 2024, the amendment allows substantial increases in the quantities of MDMA, MDA, and 2CB under subsection J.01.059(4) of Part J of the Food and Drug Regulations.
- Effectively implemented on January 16, 2024, the amendment allows substantial increases in the quantities of MDMA, MDA, and 2CB under subsection J.01.059(4) of Part J of the Food and Drug Regulations.
- Terms of the amendment now permit the following increases:
N-METHYL-3,4-METHYLENEDIOXY AMPHETAMINE (MDMA) – from 2kg to 20kg. - It enhances our competitive advantage and perfectly aligns with our vision to be the leading global supplier of GMP MDMA and other psychedelic substances."
- Optimi now has Health Canada approval to manufacture the following controlled substances:
Purpose Investments Releases 2023 Annual Report With Actuarial Review for Its Longevity Pension Fund
TORONTO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose”) is pleased to release the second Annual Report for its Longevity Pension Fund (“Longevity” or “the Fund”), the world’s first income-for-life mutual fund designed to provide income security for retired Canadians.
- TORONTO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose”) is pleased to release the second Annual Report for its Longevity Pension Fund (“Longevity” or “the Fund”), the world’s first income-for-life mutual fund designed to provide income security for retired Canadians.
- The report comprises two main sections: the first is a recap of the Fund in 2023, prepared by Purpose, and the second is a detailed independent third-party actuarial review.
- “The Longevity Pension Fund continues to deliver on its core objective and provides income security for Canadian retirees,” says Fraser Stark, President of Longevity Retirement Platform at Purpose Investments.
- The results of the Annual Review further validate that Longevity is on track to achieving its objective of providing lifetime income.
Nonprofit Sector Faces Pressing Challenges in Worker Stress, Public Trust, and Donor Participation, Shows New Report at the 2023 Upswell Summit
Independent Sector launched the report in advance of the 2023 Upswell Summit , co-hosted with Social Venture Partners (SVP) Dallas in Dallas, Texas on November 15-17, 2023.
- Independent Sector launched the report in advance of the 2023 Upswell Summit , co-hosted with Social Venture Partners (SVP) Dallas in Dallas, Texas on November 15-17, 2023.
- The 2023 Upswell Summit will provide a central meeting place for more than 600 nonprofit and foundation leaders, philanthropists, business and corporate leaders, activists, academics, journalists, and changemakers.
- The report covers sector health data, as well as Independent Sector’s analysis from 2022 through the second quarter of 2023.
- View the official PSA for the 2023 Upswell Summit here: https://youtu.be/sKKuyP41vDI
You may also follow along on social media using #Upswell2023.
COMPLY PROGRAM MANAGEMENT SOFTWARE AND ANNUAL REVIEW SERVICE LAUNCHED BY COMPLY
NEW YORK, Nov. 15, 2023 /PRNewswire/ -- COMPLY, the global market leader of compliance software, consulting and education resources for the financial services sector, has launched COMPLY Program Management and Annual Review Service, an integrated solution which addresses the market need for more comprehensive compliance resources, enabling firms to meet additional regulatory requirements and demands.
- NEW YORK, Nov. 15, 2023 /PRNewswire/ -- COMPLY, the global market leader of compliance software, consulting and education resources for the financial services sector, has launched COMPLY Program Management and Annual Review Service, an integrated solution which addresses the market need for more comprehensive compliance resources, enabling firms to meet additional regulatory requirements and demands.
- COMPLY Program Management simplifies and automates a multitude of compliance duties and deliverables, thereby reducing risk, improving efficiency and easing year-end compliance obligations.
- Additionally, for firms seeking enhanced assistance in adhering to the latest regulations, COMPLY has introduced an accompanying service offering with the COMPLY Program Management software that provides regimented and on-going compliance consulting services aimed at easing the challenges of the annual review process and defining compliance priorities throughout the year.
- With COMPLY Program Management and Annual Review Service, we combine the benefits of the wide range of solutions available from across our product portfolio, integrating software, consulting and education, and enhancing our clients' ability to develop and execute a comprehensive and scalable compliance program from a single platform.
Quit for Good Signs Global Statement of Support for Tobacco Harm Reduction
Quit For Good is a non-profit organization promoting harm reduction to mitigate the damage caused by cigarette smoke on human health.
- Quit For Good is a non-profit organization promoting harm reduction to mitigate the damage caused by cigarette smoke on human health.
- It is one of the 14 scientific organizations in four continents who support the consensus statement of SCOHRE that the WHO FCTC should not ignore the evidence in support of THR any more.
- It is also one of the two organizations based in the Philippines that signed the statement, the other being the Harm Reduction Alliance of the Philippines (HARAP).
- He said providing safer nicotine products to reduce harm for smokers is common sense as smokers are already offered nicotine replacement therapy (NRT) to quit or reduce harm.